BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/27/2021 5:24:00 AM | Browse: 677 | Download: 1606
 |
Received |
|
2021-03-01 22:23 |
|
Peer-Review Started |
|
2021-03-01 22:30 |
|
First Decision by Editorial Office Director |
|
2021-07-06 02:57 |
|
Return for Revision |
|
2021-07-06 02:57 |
|
Revised |
|
2021-07-16 07:56 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-11-11 03:17 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-11-15 03:11 |
|
Articles in Press |
|
2021-11-15 03:11 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-12-21 04:06 |
|
Publish the Manuscript Online |
|
2021-12-27 05:24 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago and Roberto Grassia |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Stefano Mazza, MD, Doctor, Doctor, Gastroenterology and Digestive Endoscopy Unit, ASST Cremona, Viale Concordia 1, Cremona 26100, Italy. stem311089@gmail.com |
| Key Words |
Inflammatory bowel diseases; Hepatobiliary disorders; Primary sclerosing cholangitis; Drug-induced liver injury; Biological drugs; Viral hepatitis |
| Core Tip |
Hepatobiliary disorders are commonly associated with inflammatory bowel diseases (IBD) and represent a management challenge. They include (1) Immune-mediated diseases that can coexist with IBD, mainly primary sclerosing cholangitis; (2) Other non-immune-mediated disorders like gallstone disease; (3) Liver injury induced by drugs used in IBD; and (4) Risks related to concomitant viral hepatitis B and C. All these conditions are summarized in this review, according to the latest literature evidence and the current clinical practice guidelines. |
| Publish Date |
2021-12-27 05:24 |
| Citation |
Mazza S, Soro S, Verga MC, Elvo B, Ferretti F, Cereatti F, Drago A, Grassia R. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World J Hepatol 2021; 13(12): 1828-1849 |
| URL |
https://www.wjgnet.com/1948-5182/full/v13/i12/1828.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v13.i12.1828 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
